ClinicalTrials.gg
CompletedNCT00081380Updated Dec 22, 2008

Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

A Phase 3 interventional study of Seroquel®, quetiapine fumarate (atypical antipsychotic) and lithium (mood stabilizer) in Bipolar Disorder, sponsored by AstraZeneca. Completed at 94 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2008-12-22.

Sponsored by AstraZeneca · Phase 3, Interventional, and Prevention

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
710
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 37 studies testing lithium in Bipolar Disorder — 1 open to participants now, 1 under way, none of them phase 3. Lithium · Bipolar Disorder.

Enrollment
Largest of 37
710 · median 49
Started
2004
with 1 other
Phase 3
9 of 37
none open now
Registered
2nd of 37
by date
Lead sponsor
3 of 37
AstraZeneca

Among the 37 studies testing lithium in Bipolar Disorder, this one has the largest enrollment, is one of 2 that started in 2004, is one of 9 in phase 3, and was the 2nd registered.

Bipolar Disorder

1,685 studies on the registry are indexed under Bipolar Disorder; 268 are open to participants now.

Browse Bipolar Disorder studies →

Open to participants now

1 of the 37 studies testing lithium in Bipolar Disorder is open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

About lithium

No approval found in the FDA or EMA files read. How studies give it is on its page →

Who these studies take

Of the 208 Bipolar Disorder studies recruiting now, 59 (28%) set no upper age limit and 136 (65%) stop at 75 or younger; 38 take children under 18; 51 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 37 studies testing lithium in Bipolar Disorder, or all of them as a file.
02

Study summary

The purpose of this study is to determine whether quetiapine when used as adjunct to lithium or divalproex is safe and effective in the maintenance treatment of adult patients with Bipolar I Disorder. The study consists of enrollment and 2 phases, the Open-label treatment Phase and the Randomized treatment Phase.

PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

03

Conditions studied

  • Bipolar Disorder

Browse trials for

Keywords

  • Bipolar I Disorder
  • Manic Depressive Disorder
  • Manic Depression, Mixed
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Open-Label

  • A diagnosis of Bipolar I Disorder, Most recent episode Manic (296.4x), or Bipolar I Disorder, Most Recent Episode Depressed (296.5x), or Bipolar I Disorder, Most recent Episode Mixed (296.6x), with or without psychotic features, as defined by - Fourth Edition (DSM-IV)
  • At least 1 manic, depressed, or mixed episode in the 2 years prior to the index episode.
  • Able to understand and comply with the requirements of the study.

Exclusion criteria

Exclusion Criteria:

Open-Label

  • Diagnosis of an anxiety disorder as defined by , which was treated with medication within the past year.
  • Known intolerance or lack of response to quetiapine fumarate or to the assigned mood stabilizer, as judged by the investigator.
  • Previously randomized into this study or D1447C00126
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double
Enrollment
710 participants
06

What researchers measure

Primary outcomes

  1. Evaluate the efficacy of quetiapine versus placebo when used as adjunct therapy to mood stabilizer in increasing time to recurrence of a mood event.

Secondary outcomes

  1. Evaluate the efficacy of quetiapine versus placebo when used as a adjunct therapy to mod stabilizer in increasing time to recurrence of a manic event.

07

Study locations

94 sites
  • Research Site
    Birmingham, Alabama, United States
  • Research Site
    Scottsdale, Arizona, United States
  • Research Site
    Little Rock, Arkansas, United States
  • Research Site
    Anaheim, California, United States
  • Research Site
    Cerritos, California, United States
  • Research Site
    Chula Vista, California, United States
  • Research Site
    Culver City, California, United States
  • Research Site
    Garden Grove, California, United States
  • Research Site
    La Mesa, California, United States
  • Research Site
    Oceanside, California, United States
  • Research Site
    Orange, California, United States
  • Research Site
    Pico Rivera, California, United States
  • Research Site
    Riverside, California, United States
  • Research Site
    Rosemead, California, United States
  • Research Site
    San Diego, California, United States
  • Research Site
    San Francisco, California, United States
  • Research Site
    Santa Ana, California, United States
  • Research Site
    Farmington, Connecticut, United States
  • Research Site
    New Britain, Connecticut, United States
  • Research Site
    Jacksonville, Florida, United States
  • Research Site
    Miami, Florida, United States
  • Research Site
    Orlando, Florida, United States
  • Research Site
    West Palm Beach, Florida, United States
  • Research Site
    Winter Park, Florida, United States
  • Research Site
    Atlanta, Georgia, United States
  • Research Site
    Decatur, Georgia, United States
  • Research Site
    Marietta, Georgia, United States
  • Research Site
    Smyrna, Georgia, United States
  • Research Site
    Honolulu, Hawaii, United States
  • Research Site
    Chicago, Illinois, United States
  • Research Site
    Hoffman Estates, Illinois, United States
  • Research Site
    Joliet, Illinois, United States
  • Research Site
    Evansville, Indiana, United States
  • Research Site
    Greenwood, Indiana, United States
  • Research Site
    Indianapolis, Indiana, United States
  • Research Site
    Wichita, Kansas, United States
  • Research Site
    Florence, Kentucky, United States
  • Research Site
    Lake Charles, Louisiana, United States
  • Research Site
    New Orleans, Louisiana, United States
  • Research Site
    Shreveport, Louisiana, United States
  • Research Site
    Baltimore, Maryland, United States
  • Research Site
    Rockville, Maryland, United States
  • Research Site
    Pittsfield, Massachusetts, United States
  • Research Site
    New Baltimore, Michigan, United States
  • Research Site
    St. Louis, Missouri, United States
  • Research Site
    Clementon, New Jersey, United States
  • Research Site
    Moorestown, New Jersey, United States
  • Research Site
    West Caldwell, New Jersey, United States
  • Research Site
    Albuquerque, New Mexico, United States
  • Research Site
    Bronx, New York, United States
  • Research Site
    Brooklyn, New York, United States
  • Research Site
    New York, New York, United States
  • Research Site
    Butner, North Carolina, United States
  • Research Site
    Raleigh, North Carolina, United States
  • Research Site
    Beachwood, Ohio, United States
  • Research Site
    Cincinnati, Ohio, United States
  • Research Site
    Dayton, Ohio, United States
  • Research Site
    Medina, Ohio, United States
  • Research Site
    Oklahoma City, Oklahoma, United States
  • Research Site
    Tulsa, Oklahoma, United States
  • Research Site
    Eugene, Oregon, United States
  • Research Site
    Portland, Oregon, United States
  • Research Site
    Emmaus, Pennsylvania, United States
  • Research Site
    Moon Township, Pennsylvania, United States
  • Research Site
    Philadelphia, Pennsylvania, United States
  • Research Site
    Charleston, South Carolina, United States
  • Research Site
    Memphis, Tennessee, United States
  • Research Site
    Austin, Texas, United States
  • Research Site
    Dallas, Texas, United States
  • Research Site
    DeSoto, Texas, United States
  • Research Site
    Houston, Texas, United States
  • Research Site
    Irving, Texas, United States
  • Research Site
    San Antonio, Texas, United States
  • Research Site
    Wichita Falls, Texas, United States
  • Research Site
    Charlottesville, Virginia, United States
  • Research Site
    Falls Church, Virginia, United States
  • Research Site
    Richmond, Virginia, United States
  • Research Site
    Virginia Beach, Virginia, United States
  • Research Site
    Bellevue, Washington, United States
  • Research Site
    Kirkland, Washington, United States
  • Research Site
    Morgantown, West Virginia, United States
  • Research Site
    Edmonton, Alberta, Canada
  • Research Site
    Vancouver, British Columbia, Canada
  • Research Site
    Victoria, British Columbia, Canada
  • Research Site
    Winnipeg, Manitoba, Canada
  • Research Site
    Halifax, Nova Scotia, Canada
  • Research Site
    Hamilton, Ontario, Canada
  • Research Site
    Kingston, Ontario, Canada
  • Research Site
    Markham, Ontario, Canada
  • Research Site
    Mississauga, Ontario, Canada
  • Research Site
    Oshawa, Ontario, Canada
  • Research Site
    Toronto, Ontario, Canada
  • Research Site
    Montreal, Quebec, Canada
  • Research Site
    Quebec, Canada
08

References and documents

Publications

  • Suppes T, Vieta E, Gustafsson U, Ekholm B. Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials. Depress Anxiety. 2013 Nov;30(11):1089-98. doi: 10.1002/da.22136. Epub 2013 Jun 12. PubMed 23761037 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Mar 2004 and a completion of Sep 2006. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 9, 2004
First posted
Apr 19, 2004
Start
Mar 2004
CompletionActual
Sep 2006
Last update
Dec 22, 2008
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 22, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00081380
Lead sponsor
AstraZeneca
First posted
Apr 19, 2004
Start date
Mar 2004
Completion
Sep 2006
Last update
Dec 22, 2008

Study contacts

AstraZeneca Seroquel Medical Science Director, MD
study director · AstraZeneca
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Lithium · Valproic Acid

Start the discussion